Related Experiment Video
Updated: Jul 3, 2025

Genome Editing in Mammalian Cell Lines using CRISPR-Cas
Published on: April 11, 2019
Expanding the DNA editing toolbox: Novel lambda integrase variants targeting microalgal and human genome sequences
Jia Wei Siau1, Asim Azhar Siddiqui2, Sze Yi Lau1
1Protein and Peptide Engineering Research Laboratory, Institute of Molecular and Cell Biology, Agency for Science Technology and Research, Singapore, Singapore.
Researchers engineered novel lambda integrase variants to precisely insert large DNA fragments into specific sites. These engineered enzymes expand DNA editing capabilities for applications in green biomanufacturing and carbon sequestration.
Area of Science:
- Synthetic biology
- Molecular biology
- Biotechnology
Background:
- Recombinase enzymes efficiently integrate large DNA, but their specificity limits applications.
- Engineering is needed to overcome sequence limitations and enhance robustness.
Purpose of the Study:
- To evolve novel lambda integrase variants for targeting non-natural DNA sequences.
- To enable precise genomic integration in key microorganisms for biomanufacturing and carbon sequestration.
Main Methods:
- Directed evolution of lambda integrase.
- In vitro specificity assays.
- In vitro and in human cell assays for targeting engineered sites.
Main Results:
- Developed lambda integrase variants with >1000-fold specificity switch for non-natural target sites.
- Demonstrated efficient targeting of a human genomic site homologous to an algal sequence.
- Showcased successful in vitro and in human cell targeting with engineered integrases.
Conclusions:
- Engineered integrase variants offer expanded DNA editing capabilities.
- These variants are valuable for targeted genomic insertion of large DNA cargos.
- Potential applications include green biomanufacturing and carbon sequestration using engineered microorganisms.
More Related Videos
09:51Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation
Published on: February 2, 2016
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019